GlobalData on MSN
Labcorp announces colorectal cancer test availability in US
ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...
Laboratory Corporation of America Holdings or LabCorp LH continues to remain in the headlines with major back-to-back developments within the company’s business. Following last week’s announcement of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results